Madurai, India
Aurolab Trust recalls
1 recall recorded since 2018, most recently on 17 September 2026. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0
Ongoing Class II Drugs
- Recall started
- 17 September 2026
- Reason
- Lack of Assurance of Sterility
- Distribution
- VA
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0874-2026
- FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.